PNT

POINT Biopharma Global Inc. Common Stock
PNT

Overview Fund Activity
Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

55 hedge funds and large institutions have $194M invested in POINT Biopharma Global Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
55
Holders Change
+21
Holders Change %
+61.76%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
19
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$14.8M
2
SCM
2
Suvretta Capital Management
New York
$15M
3
FFM
3
Fairmount Funds Management
Pennsylvania
$8.51M
4
SCM
4
Sio Capital Management
New York
$2.12M
5
GPP
5
Great Point Partners
Connecticut
$1.07M

Top Sellers

1
FCM
1
Farallon Capital Management
California
$9.56M
2
BCP
2
Berylson Capital Partners
Massachusetts
$0
3
Franklin Resources
3
Franklin Resources
California
$4.33M
4
SFM
4
Sphera Funds Management
Israel
$3.32M
5
PA
5
Perceptive Advisors
New York
$6.69M
Name Market Value Shares Shares
Change 		Shares
Change %
Osaic Holdings
51
Osaic Holdings
Arizona
$15K 2,670 +2,670 New
UBS Group
52
UBS Group
Switzerland
$14K 2,455 +2,455 New
Ensign Peak Advisors
53
Ensign Peak Advisors
Utah
$7K 1,330 +1,330 New
Citigroup
54
Citigroup
New York
$4K 664 +664 New
PNC Financial Services Group
55
PNC Financial Services Group
Pennsylvania
$2K 200 +200 New
BCP
56
Berylson Capital Partners
Massachusetts
– – -386,221 Closed
CPIG
57
Chicago Partners Investment Group
Illinois
– – -10,295 Closed
PHK
58
Point72 Hong Kong
Hong Kong
– – -8,241 Closed
CSS
59
Cubist Systematic Strategies
Connecticut
– – -3,637 Closed
CFGS
60
Concourse Financial Group Securities
Alabama
– – – –
1 2
3